Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.Disease-modifying antirheumatic drugs (DMARDs) and biological agents are critical in preventing the severe complications of rheumatoid arthritis (RA).  In this article, we review the genetic polymorphisms that affect the efficacy of DMARDs or the occurrence of adverse drug reactions associated with DMARDs in RA.
DMARDs
Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.Disease-modifying antirheumatic drugs (DMARDs) and biological agents are critical in preventing the severe complications of rheumatoid arthritis (RA).  In this article, we review the genetic polymorphisms that affect the efficacy of DMARDs or the occurrence of adverse drug reactions associated with DMARDs in RA.
DMARDs
Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.Disease-modifying antirheumatic drugs (DMARDs) and biological agents are critical in preventing the severe complications of rheumatoid arthritis (RA).  In this article, we review the genetic polymorphisms that affect the efficacy of DMARDs or the occurrence of adverse drug reactions associated with DMARDs in RA.
DMARDs
Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.Disease-modifying antirheumatic drugs (DMARDs) and biological agents are critical in preventing the severe complications of rheumatoid arthritis (RA).  In this article, we review the genetic polymorphisms that affect the efficacy of DMARDs or the occurrence of adverse drug reactions associated with DMARDs in RA.
DMARDs
Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis.Disease-modifying antirheumatic drugs (DMARDs) and biological agents are critical in preventing the severe complications of rheumatoid arthritis (RA).  In this article, we review the genetic polymorphisms that affect the efficacy of DMARDs or the occurrence of adverse drug reactions associated with DMARDs in RA.
DMARDs